LRG1 Modulates Epithelial-mesenchymal Transition and Angiogenesis in Colorectal Cancer Via HIF-1α Activation

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2016 Feb 10

PMID 26856989

Citations 86

Authors

Jingjing Zhang

Lingyin Zhu

Jingyuan Fang

Zhizheng Ge

Xiaobo Li

Affiliations

Soon will be listed here.

Abstract

Background: Leucine-rich-alpha-2-glycoprotein 1 (LRG1) has been reported to be involved in several tumors, whether it participates in colorectal cancer (CRC) progression remains unclear. Here, we investigated the biological function and underlying molecular mechanisms of LRG1 in CRC.

Methods: The mRNA and protein levels of LRG1 were assessed in CRC tissues through RT-PCR and immunohistochemistry, respectively. HCT116 and SW480 cells were treated with LRG1 siRNA, control siRNA, or recombinant LRG1. Transwell invasion assays and wound healing assays were performed to evaluate the invasion and migration of CRC cells. Epithelial-to-mesenchymal transition (EMT) markers of E-cadherin, VDR, N-cadherin, α-SMA, Vimentin and Twist1 were detected by RT-PCR and western blot. Enzyme-linked immunosorbent assay was used to measure the secretion level of VEGF-A. Conditioned medium from CRC cells was collected for endothelial cell migration, tube formation and aortic ring sprouting assays.

Results: LRG1 was overexpressed in CRC tissues and associated with cancer aggressiveness. LRG1 was further found to induce the EMT process, as well as CRC cell migration and invasion capacity. In addition, LRG1 promoted VEGF-A expression in CRC cells and contributed to tumor angiogenesis. Furthermore, HIF-1α could be induced by LRG1 in a concentration- and time-dependent manner, which was responsible for LRG1-induced VEGF-A expression and EMT.

Conclusions: The present study suggests that LRG1 plays a crucial role in the progression of CRC by regulating HIF-1α expression, thereby may be a promising therapeutic target of CRC.

Citing Articles

The pan-cancer analysis of LRG1 and its potential role in kidney renal clear cell carcinoma.

Lei Z, Song S, Geng Y, Liu B, Li Y, Min H RSC Med Chem. 2025; .

PMID: 40008188 PMC: 11848403. DOI: 10.1039/d4md00940a.

Research progress on the correlation between corneal neovascularization and lymphangiogenesis (Review).

Zhang Z, Zhao R, Wu X, Ma Y, He Y Mol Med Rep. 2024; 31(2).

PMID: 39635819 PMC: 11638739. DOI: 10.3892/mmr.2024.13412.

Gut commensal Alistipes as a potential pathogenic factor in colorectal cancer.

Fu J, Li G, Li X, Song S, Cheng L, Rui B Discov Oncol. 2024; 15(1):473.

PMID: 39331213 PMC: 11436608. DOI: 10.1007/s12672-024-01393-3.

Proteomic landscape of epithelial ovarian cancer.

Qian L, Zhu J, Xue Z, Zhou Y, Xiang N, Xu H Nat Commun. 2024; 15(1):6462.

PMID: 39085232 PMC: 11291745. DOI: 10.1038/s41467-024-50786-z.

Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer.

Huang A, Sun Z, Hong H, Yang Y, Chen J, Gao Z J Transl Med. 2024; 22(1):587.

PMID: 38902737 PMC: 11191174. DOI: 10.1186/s12967-024-05391-5.

References

Saito K, Tanaka T, Kanda H, Ebisuno Y, Izawa D, Kawamoto S . Gene expression profiling of mucosal addressin cell adhesion molecule-1+ high endothelial venule cells (HEV) and identification of a leucine-rich HEV glycoprotein as a HEV marker. J Immunol. 2002; 168(3):1050-9. DOI: 10.4049/jimmunol.168.3.1050. View

Rasheed S, Harris A, Tekkis P, Turley H, Silver A, McDonald P . Hypoxia-inducible factor-1alpha and -2alpha are expressed in most rectal cancers but only hypoxia-inducible factor-1alpha is associated with prognosis. Br J Cancer. 2009; 100(10):1666-73. PMC: 2696753. DOI: 10.1038/sj.bjc.6605026. View

Takahashi N, Takahashi Y, Putnam F . Periodicity of leucine and tandem repetition of a 24-amino acid segment in the primary structure of leucine-rich alpha 2-glycoprotein of human serum. Proc Natl Acad Sci U S A. 1985; 82(7):1906-10. PMC: 397442. DOI: 10.1073/pnas.82.7.1906. View

Haupt H, Baudner S . [Isolation and characterization of an unknown, leucine-rich 3.1-S-alpha2-glycoprotein from human serum (author's transl)]. Hoppe Seylers Z Physiol Chem. 1977; 358(6):639-46. View

Furukawa K, Kawamoto K, Eguchi H, Tanemura M, Tanida T, Tomimaru Y . Clinicopathological Significance of Leucine-Rich α2-Glycoprotein-1 in Sera of Patients With Pancreatic Cancer. Pancreas. 2014; 44(1):93-8. DOI: 10.1097/MPA.0000000000000205. View

Lynch J, Fay J, Meehan M, Bryan K, Watters K, Murphy D . MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway. Carcinogenesis. 2012; 33(5):976-85. PMC: 3334516. DOI: 10.1093/carcin/bgs114. View

Andersen J, Boylan K, Jemmerson R, Geller M, Misemer B, Harrington K . Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients. J Ovarian Res. 2010; 3:21. PMC: 2949730. DOI: 10.1186/1757-2215-3-21. View

Weis S, Cheresh D . Tumor angiogenesis: molecular pathways and therapeutic targets. Nat Med. 2011; 17(11):1359-70. DOI: 10.1038/nm.2537. View

Zhang Y, Luo Q, Wang N, Hu F, Jin H, Ge T . LRG1 suppresses the migration and invasion of hepatocellular carcinoma cells. Med Oncol. 2015; 32(5):146. DOI: 10.1007/s12032-015-0598-7. View

10.

Serada S, Fujimoto M, Terabe F, Iijima H, Shinzaki S, Matsuzaki S . Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflamm Bowel Dis. 2012; 18(11):2169-79. DOI: 10.1002/ibd.22936. View

11.

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

12.

Kim S, Xia D, Kim S, Holla V, Menter D, DuBois R . Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Res. 2010; 70(10):4054-63. PMC: 2871069. DOI: 10.1158/0008-5472.CAN-09-2110. View

13.

Hong S, Jung K, Lee H, Son M, Yan H, Kang N . SB365, Pulsatilla saponin D, targets c-Met and exerts antiangiogenic and antitumor activities. Carcinogenesis. 2013; 34(9):2156-69. DOI: 10.1093/carcin/bgt159. View

14.

Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu M . Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 2000; 60(6):1541-5. View

15.

Han W, Zhu Q, Hu J, Li P, Zhang F, Li N . Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells. Biochim Biophys Acta. 2013; 1833(6):1454-62. PMC: 3631109. DOI: 10.1016/j.bbamcr.2013.02.029. View

16.

Evans A, Russell R, Roche O, Burry T, Fish J, Chow V . VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail. Mol Cell Biol. 2006; 27(1):157-69. PMC: 1800649. DOI: 10.1128/MCB.00892-06. View

17.

Li L, Li W . Epithelial-mesenchymal transition in human cancer: comprehensive reprogramming of metabolism, epigenetics, and differentiation. Pharmacol Ther. 2015; 150:33-46. DOI: 10.1016/j.pharmthera.2015.01.004. View

18.

Yang K, Jiang L, Hu Y, Yu J, Chen H, Yao Y . Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation. J Exp Clin Cancer Res. 2015; 34:40. PMC: 4427949. DOI: 10.1186/s13046-015-0158-1. View

19.

Zhong D, He G, Zhao S, Li J, Lang Y, Ye W . LRG1 modulates invasion and migration of glioma cell lines through TGF-β signaling pathway. Acta Histochem. 2015; 117(6):551-8. DOI: 10.1016/j.acthis.2015.05.001. View

20.

Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View